Axsome Therapeutics

+$0.07 (+0.12%) Today

+$0.36 (+0.62%) As of 8:01 AM UTC after-hours

Why Robinhood?

You can buy or sell AXSM and other stocks, options, and ETFs commission-free!

About AXSM

Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications.

CEO

Herriott Tabuteau

Employees

Headquarters

New York, New York

Founded

2012

AXSM Key Statistics

Market Cap

2.27B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

648.71K

High Today

$59.65

Low Today

$57.47

Open Price

$58.77

Volume

341.55K

52 Week High

$94.10

52 Week Low

$50.05

Analyst Ratings

100%

of 13 ratings

Buy

100%

Hold

Sell

AXSM Earnings

-$0.88

-$0.59

-$0.29

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

-$0.87 per share

Actual

Available May 10, Pre-Market